ISAPP Editorial Team

Author

Articles written by ISAPP Editorial Team

81-90 of 194 articles
  • Two Free Webinars on Probiotics!

    Both webinars – eligible for continuing education credit – on probiotics involving ISAPP board members are scheduled. The first is…
    Read more
  • ISAPP works to have evidence-based usage of probiotics to prevent antibiotic-associated diarrheoa implemented in UK

    January 12, 2018. Antibiotics are amongst the most commonly prescribed drugs in UK hospitals. However, as well as treating infection…
    Read more
  • ISAPP Digs Deeper into Evidence on Probiotics for Colic with New Meta-Analysis

    January 3, 2018. Evidence exists for gut microbiota differences between infants with and without colic, with one probiotic strain of…
    Read more
  • Prebiotic definition updated by ISAPP

    June 16, 2017. Prebiotic definition updated by ISAPP. ISAPP published a consensus statement updating the prebiotic concept – Expert consensus…
    Read more
  • WGO updates Guidelines on Probiotics and Prebiotics

    April 18, 2017. – The World Gastroenterology Organisation published a 2017 update of Practice Guideline on Probiotics and Prebiotics. Currently, the…
    Read more
  • New ISAPP infographic on EU probiotic labeling

    March 20, 2017. Probiotic Product Labels in the European Union Understanding the information that is – and isn’t – on…
    Read more
  • ISAPP posts comments with the FDA on Dietary Supplements

    December 9, 2016. ISAPP posts comments with the FDA on Dietary Supplements: New Dietary Ingredient Notifications and Related Issues: Guidance…
    Read more
  • ISAPP publishes probiotic recommendations for at-risk populations

    November 10, 2016. – ISAPP, in collaboration with IPA, publishes paper on use of probiotics in at-risk populations. This paper…
    Read more
  • Reid Named Fellow of Royal Society of Canada

    Prof. Gregor Reid, PhD, a founding board member of ISAPP, a former President of ISAPP and the current advisor to…
    Read more
  • ISAPP files comments with the FDA on their partial stay of sections of their guidance for INDs

    June 28, 2016 – ISAPP disagrees with the approach FDA has taken to address their overreach of requiring investigational new drug…
    Read more